KFSHRC advances robotic surgery with a successful Ivor Lewis Esophagectomy
The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest.
Precision in the robotic system enabled surgeons to reach deep anatomical areas without large incisions, enhancing safety, reducing risks, and improving outcomes in one of the most complex cancer surgeries.
Close collaboration among surgical, anesthesia, nursing, and technical teams was key to the procedure's success. All teams worked synchronously across every stage, from pre-op planning to post-op recovery. This approach reflects KFSHRC's multidisciplinary model of care, designed to improve patient outcomes and boost clinical efficiency.
With its advanced features, the robotic surgery significantly enhanced the safety and accuracy of the esophagectomy by offering three-dimensional high-definition visualization, stable instrument control, and superior access within confined anatomical spaces. These capabilities enabled more precise dissection, better preservation of surrounding structures such as nerves and vessels and reduced intraoperative risks. The technology also made it physically easier for the surgeon to operate over an extended period.
As a medical milestone, the success of this procedure opens the door for broader applications of robotic surgery at KFSHRC. It enables more patients to benefit from advanced surgical techniques and reinforces the institution's commitment to clinical innovation, safety, and effective alternatives to traditional surgical approaches.
It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for 2025. It was also recognized as the most valuable healthcare brand in the Kingdom and the Middle East by Brand Finance in 2024 and was listed among the World's Best Smart Hospitals by Newsweek for 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
12 hours ago
- Zawya
AstraZeneca enters rare disease care in South Africa
AstraZeneca announced its entrance into rare disease care in South Africa at a launch event held at the Nelson Mandela Children's Hospital in Johannesburg. Its rare disease portfolio will bring treatments for complex conditions such as neurofibromatosis type 1 (NF1), paroxysmal nocturnal hemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS), and myasthenia gravis. The event included a panel discussion with experts from fields such as neuro-oncology, neurology, plastic surgery, and genetics. Panellists highlighted the vital need for coordinated, specialist-driven care and robust collaboration across public and private sectors to ensure that patients receive integrated support at every stage of their journey. Dr Nkuli Boikhutso, CEO of Nelson Mandela Children's Hospital, stated: 'We are honoured to be the site of this important milestone. "AstraZeneca's commitment to introducing new treatments for rare diseases offers hope for our young patients and aligns with our vision to provide world-class, specialised care for all children, regardless of their background.' Rare diseases Around the world, more than 400 million people are affected by over 10,000 known rare diseases, yet the vast majority of these conditions have no approved treatments. For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or difficult treatment options. AstraZeneca is dedicated to transforming this landscape by introducing advanced therapies, supporting earlier and more accurate diagnoses, and fostering multidisciplinary collaboration. 'AstraZeneca's entry into the rare disease space in South Africa is both a proud and hopeful moment for us,' said Deepak Arora, African cluster country president at AstraZeneca. 'Building on decades of pioneering rare disease science, we are committed to expanding access to transformational medicines for conditions such as NF1, PNH. 'This marks a significant milestone in our mission to improve the lives of patients living with rare diseases, especially children who have had very few options until now.' AstraZeneca's rare disease strategy in Africa is anchored in three key priorities: accelerating access to vital medicines, driving innovation through research and development, and expanding its global reach to make meaningful change. All rights reserved. © 2022. Provided by SyndiGate Media Inc. (
Zawya
16 hours ago
- Zawya
Saudi: Health council fines 110 employers for insurance violations
RIYADH — The Council of Health Insurance (CHI) has imposed penalties totaling SR2.5 million on 110 employers for violating provisions of the Cooperative Health Insurance Law, it announced on Thursday. The CHI stated that the violations were related to employers' failure to provide mandatory health insurance coverage to their employees and eligible family members, despite receiving prior warnings urging them to rectify their status. Under Article 14 of the Cooperative Health Insurance Law, any employer who fails to subscribe or pay insurance premiums for employees and their dependents is required to pay the outstanding premiums along with a fine not exceeding the annual subscription value per individual. Additionally, violators may face temporary or permanent bans on hiring foreign workers. These measures, the council said, are part of efforts to strengthen its regulatory role and ensure mandatory health insurance compliance, aimed at safeguarding the rights of beneficiaries and enhancing fairness and transparency in the system. CHI spokesperson Iman Al-Turaiki stressed the council's ongoing commitment to building a regulatory environment that promotes compliance and protects the rights of insured individuals and their families. She affirmed that the council continues to monitor violations and take firm action against non-compliant establishments. She also urged all employers to take immediate steps to align with the law and ensure a safe and healthy work environment by securing the required insurance coverage. © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
2 days ago
- Zawya
Saudi: SFDA shuts frozen food factory, halts production lines over serious violations
RIYADH — The Saudi Food and Drug Authority (SFDA) has shut down a frozen ready-to-eat food factory and suspended production lines at several other facilities after uncovering serious health violations that posed direct risks to consumer safety. The enforcement actions followed inspection campaigns carried out last month as part of SFDA's proactive monitoring program to ensure compliance with national food safety standards and prevent potential foodborne illnesses. In one facility producing pickles and ready meals, inspectors found poor hygiene, unsafe operating practices, and ineffective safety supervision — conditions conducive to the growth of harmful pathogens such as Listeria monocytogenes, E. coli, and Salmonella spp., all of which can cause acute food poisoning. Although the facility was given a deadline to correct the violations under Article 12 of the Food Law (Royal Decree No. M/38, dated 28/4/1440H), it failed to comply within the required timeframe. This led to the full suspension of its production lines and the initiation of legal proceedings. In a separate case, violations were detected at another facility producing ready-to-eat poultry products. These included employing unlicensed workers, lacking a valid HACCP food safety certification, storing expired food without clear separation, and using corroded, unsafe food-contact equipment. The SFDA imposed fines under Article 20 of the Food Law's executive regulations and partially suspended the facility's operations until corrective measures are taken. Additionally, the authority suspended 11 production lines across several dairy and frozen pastry plants after lab tests confirmed contamination with Clostridium perfringens, a common cause of foodborne illness. All facilities were instructed to implement corrective action plans within 30 days, including upgrading quality systems, retraining staff, and replacing non-compliant equipment. Follow-up inspections will ensure compliance. The SFDA emphasized that these actions reflect its commitment to preventive public health protection and are supported by legal provisions allowing stringent measures, including suspension, imprisonment, or fines up to SR10 million. The authority urged consumers to report any suspected food violations via the unified hotline (19999), affirming that food safety is a shared responsibility from production to the dining table. © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
